Oct 10,2022

Global Biosensors Market Report 2022: Wearable Technology to Present Significant Opportunities

The market for biosensors is anticipated to grow at a CAGR of 8.5% during the forecast period 2022 to 2030. The need for biosensors is developing as a result of a wide variety of medical applications, an increasing number of people living with diabetes, a high demand for miniature diagnostic devices, and rapid technological advancements.

View Analyst & Ambassador Comments
Go to original news
Oct 11,2022 TOP STORY

Ascensia completes Senseonics Eversense E3 European launch

Ascensia Diabetes Care announced that it successfully completed its initial European launch for the Senseonics (NYSE:SENS) Eversense E3. Eversense E3 represents Senseonics’ next-generation continuous glucose monitor (CGM) system. Eversense E3 can be used for up to six months (180 days). This doubles the wear time of its previous-generation CGM.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 11,2022

Indian researchers develop smartphone app that predicts optimal insulin amount

Researchers from the Indian Institute of Science's Robert Bosch Centre for Cyber-Physical Systems have teamed up with doctors from MS Ramaiah Medical College to develop an artificial pancreas system that monitors and controls blood sugar levels in real time.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 11,2022

GlucoTrack to begin R&D for new long-term CGM

GlucoTrack (Nasdaq:GCTK) announced that it plans to expand its product pipeline with an R&D program for a long-term continuous glucose monitor (CGM).

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 12,2022

Roche Launches cobas pulse System with Diabetes Cloud Provider Glytec

Roche has launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its own apps. The cobas pulse will start shipping to select countries in Europe, carrying a CE mark, Roche said during the J.P. Morgan Healthcare Conference. The company said it plans to seek clearances in the U.S. and other markets over the course of this year.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Oct 12,2022

Liva Health Appoints New CEO to Supercharge Global Growth

Sharif will focus on Liva Health’s ambition of scaling up its digital services of tackling chronic conditions through digital tools that deliver significant clinical outcomes, affordably at scale.

View Analyst & Ambassador Comments
Go to original news
Jan 08,2019

23andMe to integrate genetic data into Lark Health's AI health coach

Users of Lark's Wellness Program and Diabetes Prevention Program will now be able to integrate genetic data from 23andMe to get a more personalized experince.

COLLABORATION PARTNERSHIP

#product & service

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 09,2019

NHS partners with Diabetes Digital Media, Ascensia to expand access to Low Carb Program

Diabetes Digital Media (DDM), the NHS, and Ascensia Diabetes Care have all partnered to bring DDM’s Low Carb program into the NHS. Through the new agreement, the digitally delivered, evidence-based behaviour change platform will become a supported part of the NHS Apps Library.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Jan 28,2019

Interoperable artificial pancreas system reliably controls blood glucose levels in pilot trial

A recent paper published in Diabetes Technology & Therapeutics describes the design, safety and basic efficacy of a device-agnostic smartphone app that can interface with continuous glucose monitors, insulin pump devices and dosing algorithms from various manufacturers. Run on an unlocked smartphone, the interoperable Artificial Pancreas System (iAPS) smartphone app was reliable and generally maintained or improved users’ glycemic control.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 31,2019

One Drop integrates with Apple's Health Records, launches personal diabetes assistant platform

This morning diabetes self-management company One Drop announced its platform’s integration with Apple’s Health Records. As part of the integration patients who use the One Drop | Experts are able to share their EHRs with their personal diabetes coach. This gives patients the ability to share their vitals, lab results and medication history with One Drop coaches.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES